Table 7.
Correlations between PFS and molecular‐targeted therapy according to four prognostic factors
| PFS (d) | Z | P‐value | ||
|---|---|---|---|---|
| Molecular‐targeted therapy (Yes) | Molecular‐targeted therapy (No) | |||
| AGR | ||||
| ≤1.40 | 134.00 (98.75, 206.00) | 131.00 (108.00, 193.00) | −0.090 | 0.928 |
| >1.40 | 252.00 (205.75, 359.50) | 221.50 (146.75, 266.50) | −1.959 | 0.050 |
| FAR | ||||
| ≤10.63 | 246.00 (200.25, 316.50) | 195.00 (146.75, 264.25) | −1.862 | 0.063 |
| >10.63 | 125.50 (98.00, 104.00) | 131.00 (93.00, 198.00) | −0.031 | 0.975 |
| PGR | ||||
| ≤5.44 | 168.00 (115.00, 283.50) | 125.00 (81.75, 180.75) | −1.480 | 0.139 |
| >5.44 | 245.00 (192.00, 316.00) | 221.00 (144.50, 268.00) | −0.881 | 0.378 |
| FPR | ||||
| ≤18.49 | 245.00 (197.00, 345.00) | 190.00 (149.00, 271.00) | −1.139 | 0.255 |
| >18.49 | 168.00 (109.00, 288.00) | 144.50 (102.00, 218.00) | −0.817 | 0.414 |